| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 03/13/2008 | US20080064060 Major histocompatibility complex proteins for use in tissue targeted therapy of tumor antigens; diagnosing organ transplant rejection |
| 03/13/2008 | US20080064058 Using digestion, filtration and optical analysis to identify parasitic worms in beef |
| 03/13/2008 | US20080064057 Vaccine Protection Assay |
| 03/13/2008 | US20080064056 Function homology screening |
| 03/13/2008 | US20080064055 Methods for the identification, assessment, and treatment of patients with cancer therapy |
| 03/13/2008 | US20080064053 Recombinant vector for detecting agents that cause or potentiate DNA damage and tissue targeted therapy |
| 03/13/2008 | US20080064043 Using cytosine methylation as tool in detection of cell proliferative disorders; gene expression analysis; genetic imprinting |
| 03/13/2008 | US20080064042 Compositions for detection and analysis of polynucleotides using light harvesting multichromophores |
| 03/13/2008 | US20080064041 Biomap analysis |
| 03/13/2008 | US20080064040 Monitoring gene silencing and annotating gene function in living cells |
| 03/13/2008 | US20080064039 Dominant negative ligand drug discovery system |
| 03/13/2008 | US20080064038 Using allelic variation in secretory carrier membrane protein and amisyn genes as diagnostic tool in detection of nervous system disorders |
| 03/13/2008 | US20080064037 Rna-selective probes for live cell imaging of nuclear structure and function |
| 03/13/2008 | US20080064036 P75ntr Screening Assay |
| 03/13/2008 | US20080064035 Method For Determining Biophysical Properties |
| 03/13/2008 | US20080064034 Multi-Cellular Test Systems |
| 03/13/2008 | US20080064033 Hairpin oligonucleotides; peptide nucleic acids; kits |
| 03/13/2008 | US20080064032 Polynucleotides and uses thereof |
| 03/13/2008 | US20080064031 Processes for purifying and for detecting target double-stranded DNA sequences by triple helix interaction |
| 03/13/2008 | US20080064030 Cpg-Amplicon and Array Protocol |
| 03/13/2008 | US20080064029 Methods and Nucleic Acids for Analyses of Colorectal Cell Proliferative Disorders |
| 03/13/2008 | US20080064028 Quantitative Pcr Method of Detecting Specific Plant Genus in Food or Food Ingredient |
| 03/13/2008 | US20080064027 Using translocation-ETS-leukemia (TEL) gene products as tool in identifying modulators of cell proliferative disorders |
| 03/13/2008 | US20080064026 Compositions and methods for detecting and treating hiv infections |
| 03/13/2008 | US20080064025 Using nanoscale, self-signaling, antibody biosensors for use in single-step detection of preferential particle in solution |
| 03/13/2008 | US20080064024 Methods and apparatus for enzyme inhibitors analysis |
| 03/13/2008 | US20080063794 Attaching a linker to the array of microelectrodes; adding a porogen and a polymerization solution, polymerizing to form a permeation layer attached to the surface of the array through the linker; removing the porogen; active electronic matrix devices for biological assays |
| 03/13/2008 | US20080063783 Method |
| 03/13/2008 | US20080063654 Prostate Cancer Vaccine |
| 03/13/2008 | US20080063653 vector-based vaccine may well aid in the development of effective vaccines for a range of human cancers; nucleic acid; agonist polypeptide derived from a mucin tumor antigen; genetic vaccine |
| 03/13/2008 | US20080063651 therapeutic protein comprising a tenth domain of fibronectin type III; protein scaffold; antibody design; scaffold derived from a fibronectin type III (Fn3) or Fn3-like domain, function like natural or engineered antibodies; antibody mimics designed for optimal folding, stability, and solubility |
| 03/13/2008 | US20080063643 HLA-binding motif in its sequence; recognized by an HLA-A2- or HLA-A24-restricted cytotoxic T cell; nucleotide; antibody; vector; diagnosid and prognosis of hepatitis C virus infection |
| 03/13/2008 | US20080063641 Comprise a single antigen binding arm and an Fc region; exhibits enhanced stability in vivo compared to a Fab antibody fragment |
| 03/13/2008 | US20080063640 Pin-Prc Transition Genes |
| 03/13/2008 | US20080063636 polypeptides having deletions in the amino acid sequence, useful as antigens for improving vaccine therapy; treatment of Alzheimer's disease |
| 03/13/2008 | US20080063630 polynucleotides that code for polypeptides having activity for targeting heterogeneous polypeptides to the surfaces of cytoplasmic membranes, useful for analysis of proteind, delivery of cells expressing the polypeptide to a target site in vivo, preparation of an antibodies and vaccines, and gene therapy |
| 03/13/2008 | US20080063601 treatment of urogenital disorders comprising administering calcium channel blockers, such as triptolide, prodrugs and/or derivatives |
| 03/13/2008 | US20080063251 Method and Device for Identifying an Image of a Well in an Image of a Well-Bearing |
| 03/13/2008 | US20080060940 Base sequence detection apparatus and base sequence automatic analyzing apparatus |
| 03/13/2008 | DE112005003358T5 Verfahren zur Verbesserung von Organismen unter Verwendung von Flussabtastung, basierend auf verstärktem objektiven Fluss A method of improving flow of organisms using scanning based on reinforced objective flow |
| 03/13/2008 | DE112004002217T5 Proteinbildungskomplex mit einem c-Jun-Protein, Nucleinsäure, codierend denselben und Verfahren unter Verwendung desselben The same protein complex formation with a c-Jun protein, nucleic acid encoding the same and methods using |
| 03/13/2008 | CA2698597A1 Monitoring cancer stem cells |
| 03/13/2008 | CA2672246A1 Detecting nucleic acids |
| 03/13/2008 | CA2663390A1 Method for study, determination or evaluation by gene expression analysis |
| 03/13/2008 | CA2662915A1 Methods, compositions, and kits for the detection and monitoring of colon cancer |
| 03/13/2008 | CA2662863A1 Methods and compositions for the detection of protein folding disorders |
| 03/13/2008 | CA2662843A1 Identification of cancer stem cells using genetic markers |
| 03/13/2008 | CA2662730A1 Phenotypic and genotypic differences of mva strains |
| 03/13/2008 | CA2662721A1 Use of snps for the diagnosis of a pain protective haplotype in the gtp cyclohydrolase 1 gene (gch1) |
| 03/13/2008 | CA2662591A1 Method for evaluating patients for treatment with drugs targeting ret receptor tyrosine kinase |
| 03/13/2008 | CA2662501A1 Methods of predicting distant metastasis of lymph node-negative primary breast cancer using biological pathway gene expression analysis |
| 03/13/2008 | CA2662429A1 Ip-10 based immunological monitoring |
| 03/13/2008 | CA2662319A1 Retractable segmented bio-molecular collector swab system |
| 03/13/2008 | CA2661308A1 Neukinase, a downstream protein of neuregulin |
| 03/13/2008 | CA2654283A1 Methods of diagnosing and treating complications of pregnancy |
| 03/13/2008 | CA2653556A1 Method for determining fatty acid content in bovine intramuscular fat based on genotype of fatty acid synthase |
| 03/12/2008 | EP1897959A1 Target for therapy of cognitive impairment |
| 03/12/2008 | EP1897958A2 Method, polynucleotide probe, DNA chip and kit for identifying mutation of human mitochondrial DNA |
| 03/12/2008 | EP1897957A2 A method for diagnosis of tuberculosis by smear microscopy, culture and polymerase chain reaction using processed clinical samples and kit thereof |
| 03/12/2008 | EP1897949A2 Human interleukin-B50. Therapeutic uses |
| 03/12/2008 | EP1897940A1 Composition and method for diagnosing esophageal cancer and metastasis of esophageal cancer |
| 03/12/2008 | EP1897891A1 Diagnosis of hereditary spastic paraplegias (HSP) by detection of a mutation in the KIAA1840 gene or protein |
| 03/12/2008 | EP1897889A2 Method of modulating the profileration of medullary thyroid carcinoma cells |
| 03/12/2008 | EP1897540A2 Inhibition of STAT3 signal transduction for human cancer therapy |
| 03/12/2008 | EP1897016A2 Method and algorithm for quantifying polynucleotides |
| 03/12/2008 | EP1896840A1 Electrode preconditioning |
| 03/12/2008 | EP1896839A2 Analyte sensors and compositions for use therein |
| 03/12/2008 | EP1896832A2 Metal-enhanced fluorescence-based sensing methods |
| 03/12/2008 | EP1896619A2 Targets for inhibiting hcv replication |
| 03/12/2008 | EP1896618A2 Methods and compositions for determining resistance of hiv-1 to protease inhibitors |
| 03/12/2008 | EP1896617A1 Multiplexed amplification of short nucleic acids |
| 03/12/2008 | EP1896616A2 Bovine abcg2 gene missense mutations and uses thereof |
| 03/12/2008 | EP1896615A1 Method for identifying nucleotide sequences, use of the method and test kit |
| 03/12/2008 | EP1896614A1 MDRl SNP IN ACUTE RETECTION |
| 03/12/2008 | EP1896613A2 Non-in situ hybridization method for detecting chromosomal abnormalities |
| 03/12/2008 | EP1896612A2 Compositions, methods and kits for determining the presence of chlamydophila pneumoniae in a test sample |
| 03/12/2008 | EP1896611A2 Imethod, array, apparatus and test system to discriminate individuals |
| 03/12/2008 | EP1896610A2 Lyophilized pellets |
| 03/12/2008 | EP1896609A1 Impdh2 snp associated with acute rejection |
| 03/12/2008 | EP1896608A1 Il10 snp associated with acute rejection |
| 03/12/2008 | EP1896607A2 Methods and compositions for assessment of pulmonary function and disorders |
| 03/12/2008 | EP1896606A2 Methods of diagnosing cancer and chromosomal imbalance using interallelic epigenetic variations |
| 03/12/2008 | EP1896602A1 Improved primer-based amplification methods |
| 03/12/2008 | EP1896589A2 Novel genes and proteins of brachyspira pilosicoli and use of same for diagnosis and therapy |
| 03/12/2008 | EP1896582A1 Human monoclonal antibodies to programmed death 1(pd-1) and methods for treating cancer using anti-pd-1 antibodies alone or in combination with other immunotherapeutics |
| 03/12/2008 | EP1896474A1 Detectable threading intercalator |
| 03/12/2008 | EP1896084A2 Rnai modulation of hif-1 and theraputic uses thereof |
| 03/12/2008 | EP1896067A2 Vaccines for immunization against helicobacter |
| 03/12/2008 | EP1895997A2 Use of dna-pk inhibition to sensitise atm deficient cancers to dna-damaging cancer therapies |
| 03/12/2008 | EP1895900A2 Preoperative and intra-operative imaging-based procedure workflow with complexity scoring |
| 03/12/2008 | EP1735465A4 Compositions for use in identification of viral hemorrhagic fever viruses |
| 03/12/2008 | EP1704224A4 Identification of a gene expression profile that differentiates ischemic and nonischemic cardiomyopathy |
| 03/12/2008 | EP1682866A4 Gel-shell beads with adsorbed or bound biomolecules |
| 03/12/2008 | EP1672977A4 Apparatus and methods for selecting capacitated spermatozoa and uses thereof |
| 03/12/2008 | EP1664775A4 Composition for the diagnosis of retinal vascular disease comprising aldolase and method for diagnosis using it |
| 03/12/2008 | EP1639514A4 Efficient methods for multibody simulations |
| 03/12/2008 | EP1629003B1 Methods for identifying inhibitors |
| 03/12/2008 | EP1572105A4 Detection of micro metastasis of melanoma and breast cancer in paraffin-embedded tumor draining lymph nodes by multimaker quantitative rt-pcr |
| 03/12/2008 | EP1549770B1 Methods to predict cholesterol elevations during immunosuppressant therapy |
| 03/12/2008 | EP1534853A4 Methods and kits for transferases |